Plain-English translation of NCT07530887 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This study is testing whether patients with melanoma (a serious type of skin cancer) really need a second surgery after their initial tumor is removed. Currently, doctors recommend a second surgery with wider margins around where the cancer was, but this trial is investigating whether skipping that second surgery might be just as safe and effective. Researchers will follow patients for up to 5 years to see if avoiding the extra surgery changes their outcomes.
Standard treatment requires a second surgery after melanoma removal, but doctors aren't certain this procedure actually helps all patients. This trial exists to determine whether the second surgery is truly necessary, which could spare some patients from additional surgery, scarring, and recovery time while maintaining their safety.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to either receive the standard second surgery or to skip it entirely. You will visit your doctor regularly for follow-up appointments over 5 years, during which they will check for any signs of cancer returning and ask about your recovery and quality of life. The study will also track any surgical complications and how you feel overall during this time.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Netherlands